10 Oversold Software Stocks to Buy According to Analysts

4) Paysign, Inc. (NASDAQ:PAYS)

% Decline Over Past 6 Months: ~36.8%

Average Upside Potential: ~134.9%

Number of Hedge Fund Holders: 9

Paysign, Inc. (NASDAQ:PAYS) offers prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services. The company announced its annual performance analysis of pharmaceutical copay programs leveraging patient affordability solutions. Paysign, Inc. (NASDAQ:PAYS)’s dynamic business rules feature, focused on mitigating the harmful financial impact of copay maximizers on patients and pharmaceutical program sponsors, saved their clients over $100 million in 2024 alone.

Because of its ability to identify impacted claims on the first fill with 97% accuracy, the technology happens to be an industry-first and unique in the marketplace. Paysign, Inc. (NASDAQ:PAYS) expects growth in its higher-margin patient affordability programs to continue, aiding its gross margins. Furthermore, Paysign, Inc. (NASDAQ:PAYS)’s patient affordability pipeline is highly robust as it continues to add new customers, new programs, and maintain strong relationships with the leading pharmaceutical companies, further strengthening their confidence in its offerings.

Paysign, Inc. (NASDAQ:PAYS) remains focused on identifying and leveraging additional high-growth opportunities in the payments sector to expand its current product portfolio. With businesses and consumers rapidly adopting digital payment methods, the requirement for innovative prepaid programs and integrated payment processing services has increased. Therefore, Paysign, Inc. (NASDAQ:PAYS)’s expertise in such areas places it well to capitalize on this trend. Overall, the growth in the broader software industry, mainly in healthcare and fintech technology, provides a favourable environment for the company.